Authors















Kristi Mizelle, MD

Latest:

Impact of Diagnosis Delay on Long Term Lupus Outcomes

Drs. Anne E. Winkler and Kristi V. Mizelle discuss the negative long term disease outcomes noted in patients who experience a delay in their lupus diagnosis.






Laird Harrison

Latest:

Possible Mechanism and Treatment for Fibromyalgia Reported

Lysophosphatidylcholine 16:0 (LPC16:0), an oxidized lipid, may mediate the pain that people with fibromyalgia experience, according to researchers writing in the Annals of the Rheumatic Diseases.




Leah Lawrence

Latest:

GLP-1 Receptor Agonists vs Other Anti-Diabetics

A network meta-analysis compared GLP-1 receptor agonists to traditional anti-diabetes drugs based on hypoglycemia incidence, HbA1c goals, and more.


Leo Robert

Latest:

Gout and Heart Disease News Roundup

Slide show: Evidence for gout's role as a risk factor for heart disease is mixed. New studies add support.




Leonid Skorin, Jr, DO

Latest:

Young Man With Joint Swelling Sees a Spot

At a followup visit, this 36-year-old man being treated for reactive arthritis mentions seeing a dark spot in his field of vision. What does this tell you?


Les Bisson, MD

Latest:

Pediatric fractures in sports: Epidemiology and strategies for prevention

ABSTRACT: Sports activities are becoming increasingly popularamong children in the United States. The number of pediatric injuriescontinues to grow with the number of participants; up to25% of the injuries are fractures. The authors used a broad searchof databases and analyzed the current literature to help define theepidemiology and identify possible prevention strategies. Commonfracture locations include the distal radius, hand, elbow, and clavicle;90% of fractures involve the upper limb. Males sustain fracturestwice as often as females. The highest numbers of injuries occur inbicycle riding, basketball, football, and roller sports. Prospectivestudies of preventive strategies for pediatric sport fractures areurgently needed. (J Musculoskel Med. 2008;25:230-234, 254)




© 2024 MJH Life Sciences

All rights reserved.